An analysis of pericarditis: acute and recurrent

Main Article Content

Felipe Blanc Braz
Pedro Henrique Dias Rosa da Silva
Thomaz Mota Cabo Ferreira
Emilio Conceição de Siqueira

Abstract

Objective: To analyze the characteristics of acute and recurrent pericarditis. Bibliographic review: The pericardium is a double-layered membrane that surrounds the heart. Thickening and inflammation of this membrane is called pericarditis. Acute and recurrent pericarditis is caused by active inflammation of the pericardium, which is idiopathic in most cases. Acute pericarditis is the most frequent among pericardial syndromes and accounts for approximately 5% of all emergency room admissions for acute chest pain. The most frequent complication after acute pericarditis is recurrent or incessant pericarditis, reported in about 15 to 30% of patients. Final considerations: Acute pericarditis is a relatively common cause of acute chest pain that can be promptly assessed by complete anamnesis complemented by electrocardiogram and echocardiography, with recurrence being one of its main complications. Its therapy is based on exercise restriction, non-steroidal anti-inflammatory drugs (ibuprofen or aspirin) and colchicine with a proton pump inhibitor in order to protect the stomach. In addition, corticoids can be used and there are new drugs such as the monoclonal antibodies anakinra, canakinumab and rilonacept.

Article Details

How to Cite
BrazF. B., SilvaP. H. D. R. da, FerreiraT. M. C., & SiqueiraE. C. de. (2023). An analysis of pericarditis: acute and recurrent. Revista Eletrônica Acervo Médico, 23(11), e14530. https://doi.org/10.25248/reamed.e14530.2023
Section
Revisão Bibliográfica

References

1. ANDREIS A, et al. Recurrent pericarditis: an update on diagnosis and management. Intern Emerg Med, 2021; 16(3): 551-558.

2. ANDREIS A, et al. Contemporary diagnosis and treatment of recurrent pericarditis. Expert Rev Cardiovasc Ther, 2019; 17(11): 817-826.

3. CACOUB P. Recurrent pericarditis: New treatment. Rev Med Interne, 2020; 41(4): 223-225.

4. CHEEMA AH, et al. Efficacy of Anakinra in Pericarditis: A Systematic Review. Cureus, 2022; 14(10): e29862.

5. CHIABRANDO JG, et al. Management of Acute and Recurrent Pericarditis: JACC State-of-the-Art Review. J Am Coll Cardiol, 2020; 75(1): 76-92.

6. DEL BUONO MG, et al. Pericarditis Recurrence After Initial Uncomplicated Clinical Course. Am J Cardiol, 2021; 160: 112-116.

7. HAGERTY T, et al. Recurrent Pericarditis: a Stubborn Opponent Meets New Treatments in 2022. Curr Cardiol Rep, 2022; 24(8): 915-923.

8. IMAZIO M, et al. New Developments in the Management of Recurrent Pericarditis,

9. Canadian Journal of Cardiology, 2023; 39(8): 1103-1110.

10. ISMAIL TF. Acute pericarditis: Update on diagnosis and management. Clin Med (Lond), 2020; 20(1): 48-51.

11. KRUSCHE M, et al. Pericarditis is inflammation of the pericardium, which rheumatologists should know. Z Rheumatol, 2021; 80(1): 54-64.

12. LAZAROS G, et al. Acute Idiopathic Pericarditis: Is it Actually Always Idiopathic? J Am Coll Cardiol, 2021; 77(11): 1484-1485.

13. LAZAROU E, et al. Acute Pericarditis: Update. Curr Cardiol Rep, 2022; 24(8): 905-913.

14. MARTÍNEZ-SELLES M. Echocardiograms in patients with acute pericarditis. Emergencias, 2020; 32(4): 302.

15. MCCONAGHY JR, et al. Acute Chest Pain in Adults: Outpatient Evaluation. Am Fam Physician, 2020; 102(12): 721-727.

16. MCDONAUGH B, et al. Recurrent acute pericarditis diagnosed by extra-cellular volume maps. Eur Heart J, 2022; 43(14): 1440-1441.

17. PERRICONE C, et al. The Heart Matters: Contribution of Genetic Factors in Recurrent Pericarditis. Isr Med Assoc J, 2019; 21(7): 487-490.

18. SALARDA EM, et al. An unusual cause of acute pericarditis: a case report. Eur Heart J Case Rep, 2021; 5(2): ytaa535.

19. SILVESTRE JS. Modeling Acute Pericarditis: An Inflammatory Step Toward Tailored Therapeutic Strategies. JACC Basic Transl Sci, 2021; 6(2): 151-153.

20. TOMBETTI E, et al. Novel Pharmacotherapies for Recurrent Pericarditis: Current Options in 2020. Curr Cardiol Rep, 2020; 22(8): 59.